Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Must come out with one or more news,what about the trial
It is November. Anybody know what is happening? It sure would be nice to see some good news!
I have long time to see so big volume and all was buy, something good smells?
Did the trial start? What is the best interest for RMCP? Sell company/ patents to another company, new leadership or remain status quo?
you have a link? I searched a bit but saw nothing about the current case.
Hopefully 2017 is better if they can make it till then
It starts on October 4. It is public info. Many documents have been filed. Think they need more time they are asking to suspena some more docs from one of the shorts. It's online South Carolina punch in the company name
Anyone know how we can follow the trial?
When it will start and any other info that is public information released in one way or another?
Trial is in October for Ron. Flip a coin who knows. I know it has to be tough to get going again. Basically this lawsuit makes it impossible to get any lenders to talk to them. Could be the end of RMCP
Ron Wheet was charged by the FBI back in May. Does anyone know what is happening. Maybe RMCP gets some new blood and a new life!!! I always thought the syringe was a great product.
Today too 0002, I think R/S is on the way and this is to bad.
Done bogey...this is a real turd. I will check back end of year and see if they are in business.
esi23, Please remove the Lobster post from the highlighted top.
That post is so irrelevant to the current smell of death that surrounds the corps of RMCP.
I can't find anything encouraging and I am afraid for any R/S as a surprise, already I loose then I will loose everything on this one. Lets hope will not happen.
I though there was suppose to be a trial in March. Does anybody know what is going on?
I doubt we will see soon.
The SEC has simply found a way to string this out for aan extended time.
I doubt there could be a resolution to the latest charges in less than a year and if that trial gets appealled, years.
I agree 100 percent bogey. We shall soon see
Here's an interesting spin...
The latest charges and indictment of the criminal version of what the SEC already has underway sort of smells like the SEC is so determined to nail Ron and RMCP that it has followed up with this.
It could be that after putting up 9 lawyers and getting a mistrial, due to a hung jury, that they have become afraid they might just lose the case in the retrial.
On one hand, it could be a positive sign that they are losing confidence in winning in March. On the other hand, it makes you realize if the Gov't wants to squash you bad enough, they can. Unlimited funds are available to the SEC and they sure as hell don't want to lose a case like this.
Is a tick still involved with a dog after all of the blood has been sucked out?
Is Ron Wheet involved at all with RMCP anymore? Where does the company go from here?
Courtesy SCION: Former CEO of medical firm charged with securities fraud, conspiracy
http://investorshub.advfn.com/boards/manage_msg.asp?message_id=120484437
By Ashley Heffernan
aheffernan@scbiznews.com
Published Feb. 11, 2016
http://www.charlestonbusiness.com/news/56914-former-ceo-of-medical-firm-charged-with-securities-fraud-conspiracy
The former CEO of a Lowcountry medical business is facing securities fraud charges.
Rondald L. Wheet, 51, was chairman and CEO of Revolutions Medical Corp., a Nevada corporation with its principal office in Charleston. The company develops safety medical devices such as the RevVac auto-retraction vacuum safety syringe.
Wheet and Bryon Scott Key, 45, who was the corporation’s investor relations representative and assistant sales manager, were both charged in an indictment with conspiracy to commit securities fraud, securities fraud, conspiracy to defraud the United States and making a false statement. Key additionally was charged with two counts of money laundering, according to a news release from U.S. Attorney Bill Nettles.
Revolutions Medical Corp.’s common stock is publicly traded and registered with the Securities and Exchange Commission. The indictment accuses Wheet and Key of engaging in a scheme to fraudulently issue shares of Revolutions Medical stock.
“This district is applying significant resources to Securities and Exchange Commission cases,” Nettles said in the release. “This mission of enforcing SEC cases is essential to a stable economy.”
Assistant U.S. Attorney Dean H. Secor of the Charleston office will prosecute the case, which was investigated by the FBI.
The maximum penalty for both conspiracy to commit securities fraud and for securities fraud is 25 years’ imprisonment. The maximum penalty for conspiracy to defraud the United States and for making a false statement is five years’ imprisonment. Each count of money laundering carries a maximum penalty of 20 years in prison, the release said.
Reach staff writer Ashley Heffernan at 843-849-3144 or @AshleyBHeff on Twitter.
http://www.charlestonbusiness.com/news/56914-former-ceo-of-medical-firm-charged-with-securities-fraud-conspiracy
That's progress. I heard they have the re trial end of March it will be over Maybe by summer we will be happy
I requested and received an email from a RMCP representative stating they are working on raising capital to manufacture all the sizes of syringes and "shareholders will hear something about this within the next 60 days"
Can't get any call backs who knows. Someone is sitting on the bid with 9.8 million shares thou out of nowhere.
I will. Have been calling Ron and Scott daily no answer
Via phone call from another shareholder a week or so ago.
Don't know where they got it.
I have not seen anything in print, yet.
Timing is about right and you can be sure that Ron would have put out a PR if it had been dropped.
You seem to be somewhat in-the-know, see if you can dig around and verify it.
Where did you see retrial ?
Happy Groundhog Day for rmcp owners.
This year will be no different than previous years.
Ron will be completely consumed by the SEC retrial coming in March.
There is No money to fund the defense.
So, he will make some stock diluting deal to fund the lawyers to defend himself with company money...Exceeding the authorized shares....
No one will touch the product because the company is toxic....
Oh, wait a minute, you've all seen this movie before.
It's a horror picture show.
Happy New Year to you all.
I will remove when I get back away for holidays. Need a PC I'm working off of iPad. Enjoy
MERRY CHRISTMAS AND HAPPY NEW YEAR TO ALL
esi23, please remove the "Lobster" message from the top of the page.
I assume as the sole moderator of this board, you are able to do that.
It is very irrelevant now.
And it obviously failed to positively affect the company or it's stock.
Is green anyway, I hope tomorrow and all the week too.
I think tomorrow Monday will go up .001-.002 (I hope)
According to even Yahoo statistics page on rmcp,
Shares Outstanding5: 278.83M.
And keep in mind that the company is not current on filings.
And that is simply shares outstanding.
Who knows how many shares are about to be created in any given month due to the ongoing financing commitments that Ron has made. Or by options and warrants.
But, if it makes you feel better to use 215 million, my argument is still valid.
And esi, this is in no way a 'clean shell'.
Don't forget that it would have to be BK'd to get out from under the creditors, like the $20+ million owed to Yeso-med.
There is only one way for this thing to rise from the dead.
A production/sales commitment that actually started producing more revenue than the Yeso debt is rising (2,500,000 syringes per month)
I know it is tiring, but the SEC filings have a lot of these details.
At least until Ron stopped filing.
A Clean shell sells for 750k. Way undervalued Until updated financials no one knows
Market cap 215k
Outstanding 215 million
So a .015 price per share would put a 3 mill market cap
Why would it recover?
Without an ongoing sales contract with proven revenue and earnings and seeing that the Chinese factory has been mothballed for so long, it would be costly to turn back on, why would it rise at all?
Heck that factory might not even exist anymore. And how would we even know? You think they would admit that?
The SEC will have to declare their intentions of a retrial or not, soon.
Perhaps before the end of the year.
Not to poo poo the dream bed, but since this thing is diluted to the tune of 300 million shares (plus who knows how many options and hidden shares), for every cent of share price makes the company's market cap $3 million. A little company that comes out with a new product is sometimes worth betting on to see if the company can exploit it. But in this case, the company has proven for 10 years or more they can't. At least not the current folks.
Refer back to paragraph 1, above.
First, to even hope the pps will rise at all, for the first time in Ron's life, he would have to actually succeed at something. It's like going to the dog races and using the rule that when the dogs come out, if you see one of them take a dump, bet on that one.
Pennies are fine, $0.10 would be better!!! Does anyone know if there are any sales and has there been production of any syringes? Sure would be nice to get some good news.
May be time to add soon. Strong close
Trial behind them......maybe some updates soon.
Hopefully the shorting will disappear and we recover to the several pennies soon
Thank you for your explanation. I think RMCP has a great product and should make an impact in the medical field. I hope it really takes off.
They have never done any business.
But, yes, they can move on and try to find a buyer of the product.
Perhaps without the SEC cloud, some companies or countries will be more interested in them.
Of course, the SEC can request a retrial, since it was a hung jury, I believe.
That would take many months or perhaps a year.
So, in the mean time, if they finally succeed in getting production going and making money, it would be very timely.
What does this mean? Can RMCP get back to doing business and start getting large sales orders for their safety syringes and start making serious money? Hoping this is good news!!!
Press Releases
Email Alerts
IR Contacts
RSS News Feed
Email from RMCP:
No Verdict in SEC Versus Revolutions Medical Corporation and CEO
CHARLESTON, SC -- (Marketwired) -- 11/20/15 -- In the court case styled Securities and Exchange Commission v. Revolutions Medical Corp. and Rondald L. Wheet, Civil Action No. 12-cv-03298-LMM, United States District Court, Northern District of Georgia, Atlanta Division, after hearing evidence for two weeks and deliberating for over four days, an eight person jury informed the court on Thursday afternoon, November 19, 2015, that it was hopelessly deadlocked and could not unanimously agree on a verdict. The jury was then dismissed by the court. No date for a retrial of the case has been set by the court.
About Revolutions Medical Corporation
Revolutions Medical Corporation (OTC PINK: RMCP) is a safety medical device company. Its proprietary products and technologies include: the RevVac™ auto retraction vacuum safety syringe and prefilled vacuum auto-retraction safety syringes.
For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com/
To be added to the Revolutions Medical investor email list, please email: investment@revolutionsmedical.com with RMCP in the subject line.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
CONTACT:
Revolutions Medical Corporation
Tel.: (843) 971-4848 Ext #1
Investor Relations
Source: Revolutions Medical Corporation
Released November 20, 2015
Anybody know anything about sales or the trial? The silence is deafening!!!
Followers
|
78
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3154
|
Created
|
10/20/08
|
Type
|
Free
|
Moderators |
May/June 2014. First PR in over a year out recently. UPDATES AND IBOX UPDATES FORTHCOMING..
About Revolutions Medical Product - RMCP
Revolution Medical's products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion. The Rev Vac safety syringe and the Rev ColorMRI have not yet been cleared by the FDA for sale in the United States.
Since inception, the Company’s principal business has been to complete the development of and to commercialize color MRI Technology. The technology consists of software, which uses various color masks to produce full-color composite images from gray-scale MRI output. The resulting color images can be quickly viewed individually or all together as a “riffle stack”.
A riffle stack consists of the individual MRI images assembled to create a single composite image that contains the data from the individual images. The riffle stack allows a radiologist, using a computer mouse, to page through the images, creating a 3-D appreciation of the colorized MRI output even though the images themselves are not 3-D.
The software program can also segment the data and create a true 3-D image of the area to be examined. For instance, bone, fluid and other tissue displayed in an MRI scan of the head can be electronically eliminated to allow a 3-D rendering of just the brain.
The color images can be transferred to a CD-ROM or other digital storage device, instead of bulky film, for storage or for a patient to take to their referring physician. Because the color images are transferred to digital storage in a standard *.jpeg format, the color images can be viewed on any PC without the need for special software. The Rev ColorMRI has not yet been cleared by the FDA for sale in the United States.
Color MRI Video: http://www.revolutionsmedical.com/RevMed-ColorMRI-Video.php
The Rev Vac Safety Syringe and Phlebotomy (blood drawing) Device operate the same as a standard syringe and device. No additional training, skills, or procedures are necessary. The both products work on a vacuum principle, where pressing the plunger in them creates a vacuum. When the plunger reaches the bottom, the needle is captured. A further push on the plunger breaks the seal, and the needle retracts into the plunger barrel. The vacuum is maintained, so the needle cannot be removed from the plunger.
Revolutions Medical owns the patents and will manufacture a disposable retractable syringe and phlebotomy device. The products use a proprietary patented technology in which a vacuum causes the needle to retract into the barrel of the syringe or device after an injection is administered or blood is drawn. Prototype units have been produced and tested, but no units have been manufactured. The products have been designed to be manufactured at a cost that is approximately equal to the cost of traditional disposable syringes and phlebotomy devices and are intended to be a safe replacement for existing non-safe syringes and phlebotomy devices and even currently marketed syringes and devices labeled as safety products.With traditional syringes and phlebotomy devices, a needle contaminated with a patient’s blood remains a danger to healthcare professionals handling the needle until it is permanently disposed of in a proper biohazard containment unit. Revolutions Medical’s safety products do not present a “needlestick” hazard to health professionals after use because the contaminated needle is retracted into the barrel of the safety product and locked in place. The Rev Vac safety syringe has been cleared by the FDA for sale in the United States.
Safety Syringe Video: http://www.revolutionsmedical.com/RevMed-RevVacSafetySyringe.php
Management
Rondald Wheet - CEO, Chairman of the Board
Mr. Wheet has over fifteen (15) years experience in the investment banking industry and while working for several NASD registered broker dealers has raised in excess of $100 million for small cap companies. He held five licenses with the NASD; series 4, 7, 24, 63, and 65. He operated in a management and principal capacity for 10 years during that time and was a compliance officer for 2 years. He worked for investment firms such as Cohig & Associates, Scott and Stringfellow, Fortress Financial, and RichMark Capital. He was in charge of opening up three different brokerage offices from the beginning, including finding ideal office space, hiring personnel, becoming NASD compliant and turning them into successful branch offices. He started his own consulting business in 2002, Mansfield Garrett, Inc., and worked with many start up and micro cap companies; giving advice on capital raising, strategic partnerships, stock awareness, hiring top management and going to the public market. He served on the Board of Directors for Clear Image, Inc. since 2004. Ron is past President of the Metropolitan Exchange Club of Charleston, SC. He received a Bachelor of Science degree from the University of Towson in both Finance and International Business in 1987.Thomas O’Brien - President
Mr. O’Brien has more than twenty (20) years of general management experience in the medical device industry. He has special expertise in domestic and international sales, marketing and distribution of high technology medical systems and services. He has held executive positions with medical industry leaders such as Pfizer, Toshiba, and Johnson and Johnson owned Technicare Corporation. In 1995 he joined Spectrum Technology, a cosmetic laser company, as Vice President of Sales and Marketing. Spectrum was acquired by Palomar Corporation in 1996, and Mr. O’Brien went on to become Executive President for all of the Palomar companies. In 1996/1997 he became the President and CEO of Cosmetic Technology International, a cosmetic laser center business operating worldwide. He has most recently been the President and CEO of BioTrack, Inc. which has developed a device for the localization of breast cancer. He has also been CEO of Medical Online, Inc., an online internet medical consulting company. He has received a B.S. in foreign languages from the University of Maryland, served in the U.S. Air Force Security Service and also at the National Security Agency as a Chinese linguist.
Contact Info
Website: http://www.revolutionsmedical.com
INVESTMENT
investment@revolutionsmedical.com
Scott Key: 843-408-6265
CORPORATE HEADQUARTERS
2073 Shell Ring Circle
Mount Pleasant, SC 29466
843-971-4848 office
843-971-6917 fax
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |